Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2005
11/17/2005CA2568241A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1594938A1 Electrochromic compounds
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594863A1 Tri(cyclo) substituted amide glucokinase activator compounds
11/16/2005EP1594856A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
11/16/2005EP1594848A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
11/16/2005EP1594846A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
11/16/2005EP1594842A1 Cyanopyridone derivatives as liquid crystals
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
11/16/2005EP1594508A2 Novel bicyclic compounds and compositions
11/16/2005EP1421634B1 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/16/2005EP1379138B1 Liquid formulations for dermal application in treatment of parasitic insects in animals
11/16/2005EP0944583B1 Novel compounds useful as therapeutic agents and assay reagents
11/16/2005EP0873406B1 Protein induced by deprenyl
11/16/2005EP0834074B2 Detection of transmembrane potentials by optical methods
11/16/2005CN1696116A 0-(5,6,7,8-tetrahydro-2-naphthyl)-N-(6-methoxy group-2-pyridyl)-N-methyl methyl thiocarbamate and its prepn.
11/16/2005CN1227254C Pyridone compound and its prepn process
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227241C Arylpiperazines having activity at the serotnin 1A receptor
11/16/2005CN1227239C Method for preparing substituted oxazole
11/16/2005CN1227234C Substituted iminoazines
11/16/2005CN1227233C 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
11/16/2005CN1227232C Process for preparing non-steroid glucocorticoid receptor regulator
11/16/2005CN1227231C Ether and amide compounds as medicine for treating glycuresis and preparing process thereof
11/15/2005US6965032 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates and their preparation and use
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/10/2005WO2005105807A1 Process for producing pentacyclic taxane
11/10/2005WO2005105794A1 Synthesis of antidiabetic rosiglitazone derivatives
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105766A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105748A1 4-halogenalkylpyridin-3-sulphonamides, method for producing same, agents containing same, and use thereof as agents for pest control
11/10/2005WO2005105747A1 VAPOR PHASE CATALYTIC CHLORINATION OF β-PICOLINE
11/10/2005WO2005105746A1 Organometallic complex, luminous solid, organic el element and organic el display
11/10/2005WO2005105745A1 Process for the production of cyclic diketones
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105735A1 Phenoxyacetic acid derivatives as ppar agonists
11/10/2005WO2005105733A1 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005WO2005105732A1 Substituted methyl aryl or heteroaryl amide compounds
11/10/2005WO2005105729A1 Polyamine analogs that activate antizyme frameshifting
11/10/2005WO2005105726A1 Novel compounds, their preparation and use
11/10/2005WO2005105725A1 Novel compounds, their preparation and use
11/10/2005WO2005105718A2 Process for the production of cyclic diketones
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005WO2004087310A9 Ti-pillared clay based vandia catalyst and process for preparation
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005US20050250947 Reacting a cyanide source (potassium cyanide) with a halo-2-fluoropyridine to form a halo-2-cyanopyridine (tetraalkylonium salt catalyst); catalytic hydrogenation to form the aminomethyl derivative; amidation with a benzoyl halide; N-[(3-chloro-5-trifluoromethyl-2-pyridyl)methyl]-2,6-dichlorobenzamide
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005US20050250857 Gelling agents
11/10/2005US20050250824 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
11/10/2005US20050250818 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof
11/10/2005US20050250774 N-{2-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-4-yl}-N'-(1 H-indol-3-ylmethylene)-hydrazine; interleukin IL-12 overproduction-related disorder; antiinflammatory agent; autoimmune diseases: multiple sclerosis, sepsis, neuropathies, cirrhosis, hepatitis, diabetes, arthritis
11/10/2005US20050250771 Substituted indoles and their use as integrin antagonists
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005DE4303335B4 Ferroelektrische Flüssigkristall-Mischungen mit kurzer ferroelektrischer Ganghöhe A ferroelectric liquid crystal mixtures with a short pitch ferroelectric
11/10/2005CA2565665A1 Synthesis of antidiabetic rosiglitazone derivatives
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2565013A1 Method for producing pentacyclic taxans
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2563443A1 Therapeutic formulations of desoxyepothilones
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005CA2562152A1 Process for the production of cyclic diketones
11/10/2005CA2555862A1 Polyamine analogs that activate antizyme frameshifting
11/09/2005EP1593679A1 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands
11/09/2005EP1593673A1 Acrylamide derivative, process for producing the same, and use
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1593667A1 Amine derivative
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1592696A1 Salts comprising cyanoborate anions
11/09/2005EP1592667A2 New mono-acylated o-phenylendiamines derivatives
11/09/2005EP1592666A1 2,3 -bipyridines derivatives as selective cox-2 inhibitors
11/09/2005EP1592665A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/09/2005EP1592657A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
11/09/2005EP1592656A2 Medicinal compounds
11/09/2005EP1592428A1 NEW CRYSTALLINE MODIFICATION OF 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N- 6-(1,1-DIOXO-1&lgr; sp 6 /sp -THIOMORPHOLIN-4-YL)-4(4-F LUORO-2-METHYL-PHENYL)-PYRIDIN-3-YL -N-METHYL-ISOBUTYRAMIDE
11/09/2005EP1592425A2 New arylpiperazinyl compounds
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1206427B1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions
11/09/2005EP1165576B1 Process for preparing amine platinum complexes
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1019365B1 Novel compositions for the delivery of negatively charged molecules
11/09/2005EP0988285B1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp
11/09/2005EP0966440B1 Method of production and method of separation of 2,4'-dipyridyl derivatives and methods of production of benzoxazepine derivatives and salts thereof
11/09/2005CN1694891A Neutral metallic dendrimer complexes
11/09/2005CN1694880A 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694700A Non-nucleoside reverse transcriptase inhibitors
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 633